摘要
目的应用多重PCR方法检测初诊成人急性淋巴细胞白血病(ALL)患者的克隆性免疫球蛋白(Ig)和T细胞受体(TCR)基因重排,为实时定量RT—PCR(RQ—PCR)法监测ALL患者体内的微量残留病(MRD)奠定基础。方法参照BIOMED-2协作组制定的Ig和(或)TCR检测方法,设计96条不同的PCR引物,分成14个混合管,通过多重PCR,分别检测患者骨髓单个核细胞的IgH、IgK、TCRB、TCRG、TCRD克隆性基因重排。结果在22例成人B系ALL患者中,Ig克隆性重排检出率为96%,其中IgH为86%,IgK为14%。在18例成人T系ALL患者中,TCR克隆性重排检出率为100%,其中TCRB为83%,TCRG为78%,TCRD为39%。两个及两个以上克隆性标志物的检出率在B和T系ALL中分别为91%(22例中20例)和89%(18例中16例)。结论BIOMED-2协作组设计的14管多重PCR引物和方法,几乎可检测到淋巴细胞白血病患者体内所有占优势的克隆性T、B细胞增殖群体,方法简便、可靠、覆盖面广,适用于成人ALL患者基凶重排检测和MRD监测。
Objective To provide the evidence of RQ-PCR-based assessment of minimal residual disease(MRD), the clonal immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements were identified in newly diagnosed adult patients with acute lymphoblastic leukemia (ALL) by multiplex PCR protocols. Methods Forty newly diagnosed adult patients with B-lineage(B-) and T cell (T-) ALL were involvled in this study. All DNA samples were obtained from the bone marrow (BM) mononuclear ceils (MNC). IgH, IgK,TCRB,TCRG and TCRD gene rearrangements were detected by BIOMED-2 multiplex PCR protocols, which included 96 different primers and 14 muhiplex PCR tubes. Results The clonal immunoglobulin(Ig) rearrangements were found in 96% of B- ALL, 86% being IgH and 14% IgK. While in T-ALL, clonal TCR rearrangements were found in all of the patients, 83% being TCRB,78% TCRG and 39% TCRD. More than two clonal markers were found in 91% of B- ALL and 89% of T- ALL patients. Conclusions The detection rate of clonal rearrangements using the BIOMED-2 14 nmhiplex PCR tubes is unprecedentedly high, which can detect virtually all clonal B and T-cell proliferations. It can be used for diagnostic clonality studies as well as for the identification of PCR targets suitable for the detection of minimal residual disease.
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2008年第10期676-678,共3页
Chinese Journal of Hematology
关键词
基因
免疫球蛋白
基因
T细胞受体
基因重排
聚合酶链反应
多重
白血病
淋巴细胞
急性
Gene, immunoglobulin
Gene, T cell receptor
Gene rearrangement
Polymerase chain reaction, multiplex
Leukemia, lymphocyte, acute